Andrew J. Forman

Partner
Washington,  DC  U.S.A.
Phone202-862-2243

Peer Rating
N/R
 N/R

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials
 

Practice Areas

  • Antitrust
  • Antitrust Litigation & Civil Investigations
  • M&A Clearance & Counseling
  • Grand Jury and Cartel Investigations, Amnesty, and Compliance
  • Litigation
 
Contact InfoTelephone: 202-862-2243
Fax: 202 862 2400
http://www.cadwalader.com/professionals/andrew-forman
 
University Washington University, St. Louis, B.A., with honors, 1995
 
Law SchoolGeorgetown University Law Center, J.D., cum laude, 2000
 
Admitted2000, Maryland; 2002, District of Columbia
 
LanguagesFrench
 
Biography

Andrew Forman's practice involves counseling clients in a wide range of antitrust matters, with a specific focus on mergers and acquisitions, joint ventures, and representing clients in connection with investigations by the U.S. Department of Justice and the Federal Trade Commission (FTC). Andy also has experience in private antitrust litigation, including antitrust class action litigation. He has represented clients in matters involving a variety of industries, including the software, pharmaceutical, airline, automobile, semiconductor, industrial and engineered products, and consumer products industries. Among the clients Andy has represented are US Airways, Pfizer, Microsoft, Eli Lilly, Anheuser-Busch Inbev, and Goodyear.

Recognized as a leading antitrust lawyer, Andy was recommended in The Legal 500 (2012 -2013) for his work in merger clearances and was part of the team accepting Benchmark Litigation's award for 2013 U.S. Antitrust Group of the Year and for a national Impact Case of the Year awardfor the US Airways/American merger clearance . His work for US Airways in connection with its merger with American Airlines was also recognized by Global Competition Review as the 2014 Matter of the Year .

Prior to joining Cadwalader, Andy worked for the FTC's Bureau of Competition (Mergers I), where he helped lead antitrust investigations in large mergers and acquisitions in the pharmaceutical, medical device, consumer products, industrial products, and aircraft components industries.

Andy received his J.D., cum laude, from Georgetown University and his undergraduate degree, as an Honors Graduate, from Washington University in St. Louis. Following law school, he served as a judicial law clerk for the D.C. Court of Appeals. He is admitted to the bar in the District of Columbia and Maryland.

News & Resources

NEWS

News Releases

Cadwalader Advises Acorda Therapeutics on Merger Agreement to Acquire Civitas Therapeutics

Sep 24, 2014

Cadwalader Recognized Among Leading Firms in The Legal 500 US 2014

Jun 27, 2014

Cadwalader's Antitrust Group Captures Pair of 2014 Global Competition Review Awards

Mar 26, 2014

Cadwalader Nominated for Three Key 2014 Global Competition Review Awards

Feb 21, 2014

Benchmark Litigation Names Cadwalader the “Antitrust” Practice of the Year in U.S.

Jan 30, 2014

Cadwalader Assists US Airways in Settlement with DOJ on Merger with American Airlines

Nov 14, 2013

Cadwalader Recognized in 2013 Edition of The Legal 500 US

Oct 25, 2013

The Legal 500 Recognizes More than 15 Cadwalader Practices and 47 of the Firm's Lawyers Across U.S. Offices

Jun 06, 2012

Cadwalader Promotes Three to Partnership

Jan 16, 2012

Cadwalader Assists Microsoft in Securing Regulatory Approval for Search Alliance with Yahoo!

Feb 22, 2010

Cadwalader Names Five Special Counsel

Sep 01, 2009

Recent Press

New Deals - Lawyers on Major Transactions

Jan 29, 2009

Recognition

Cadwalader Recognized Among Leading Firms in The Legal 500 US 2014

Jun 27, 2014

Cadwalader's Antitrust Group Captures Pair of 2014 Global Competition Review Awards

Mar 26, 2014

Cadwalader Recognized in 2013 Edition of The Legal 500 US

Oct 25, 2013

2012 Legal 500 US

Jun 06, 2012

RESOURCES

Clients & Friends Memos

FTC Continues Aggressive Posture on Reverse Payment Settlement Agreements with Reference to Disgorgement

Apr 03, 2014

FTC Continues Antitrust Focus on Health Care Sector With Upcoming Two-Day Health Care Competition Workshop

Feb 21, 2014

China's Simplified Merger Review Program May Significantly Reduce Wait Times for Certain Global Transactions

Feb 19, 2014

Takeaways from Government Victories in Recent Antitrust Merger Trials

Feb 03, 2014

FTC Announces 2014 Thresholds for Merger Control Filings Under HSR Act and Interlocking Directorates Under the Clayton Act

Jan 21, 2014

Settlement of the US Airways/American Airlines Merger Litigation Highlights Changing Antitrust Landscape

Nov 19, 2013

FTC Expands Reporting Requirements for Transfers of Pharmaceutical Patent Rights

Nov 11, 2013

Lessons Learned from Recent Penalties for Failures to File HSR Notification

Jul 15, 2013

Supreme Court Decision Compels Brand-Name and Generic Drug Manufacturers Alike to Rethink Hatch-Waxman Litigation Strategies

Jun 18, 2013

Supreme Court Rules Phoebe Putney's Acquisition is Not Immune Under the State-Action Doctrine

Feb 21, 2013

HSR Thresholds Increased for 2013

Jan 14, 2013

Recent Actions by Supreme Court and U.S. Antitrust Authorities Illustrate Continued Focus on Antitrust Issues in the Health Care Sector

Dec 12, 2012

FTC/DOJ Announce Significant Changes to HSR Premerger Notification Form

Aug 02, 2011

Experience

Antitrust representations include:
•Acorda Therapeutics, Inc. in its pending acquisition of Civitas Therapeutics, Inc.
•Eli Lilly & Company in human health and animal matters, including the proposed $5.4 billion acquisition of Novartis Animal Health.
•Salix Pharmaceuticals in its pending combination with Cosmo Technologies to form Salix Pharmaceuticals, plc.
•US Airways in its $17 billion merger with American Airlines.
•Vertis Holdings, Inc., an advertising and direct mail company, in connection with its acquisition out of bankruptcy by rival Quad/Graphics, Inc..
•US Airways in its slot transaction with Delta Air Lines.
•Pfizer Inc. in its $68 billion acquisition of Wyeth Pharmaceuticals.
•Microsoft Corporation in numerous antitrust matters.
•elan Corporation PLC in the $3.3 billion sale of its multiple sclerosis joint venture interest to Biogen Idec, Inc.
•Anheuser-Busch InBev in various matters.

 
ISLN916984357
 

Documents by this lawyer on Martindale.com

Subscribe to this feed

FTC Continues Aggressive Posture on Reverse Payment Settlement Agreements with Reference to Disgorgement
Andrew J. Forman,Daniel J. Howley,Jessica Michaels,Charles F. (Rick) Rule, April 20, 2014
In two recent statements, the FTC reaffirmed its intention aggressively to pursue reverse-payment patent settlement agreements in the pharmaceutical industry.

Takeaways from Government Victories in Recent Antitrust Merger Trials
Andrew J. Forman,Daniel J. Howley,Jonathan S. Kanter,Charles F. (Rick) Rule,Eric Sega, February 10, 2014
Recent government victories in the antitrust challenges to the consummated mergers of Bazaarvoice/PowerReviews and St. Luke’s/Saltzer are the latest in a string of trial successes by the Department of Justice (“DOJ”) and the Federal Trade Commission (“FTC”),...

FTC Announces 2014 Thresholds for Merger Control Filings Under HSR Act and Interlocking Directorates Under the Clayton Act
Andrew J. Forman,Ngoc Pham Hulbig,Jonathan S. Kanter,Christian J. Lorenz,Charles F. (Rick) Rule, January 31, 2014
The Federal Trade Commission (“FTC”) has announced its annual revisions to the dollar jurisdictional thresholds in the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”); the revised thresholds will become effective 30 days after the date of...
Profile Visibility
#3,493 in weekly profile views out of 53,207 lawyers in Washington, District of Columbia
#111,830 in weekly profile views out of 1,616,736 total lawyers Overall

Office Information

Andrew J. Forman

700 Sixth Street, N.W.
WashingtonDC 20001




Loading...
 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now